These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38004510)

  • 21. Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation.
    Khan S; Baboota S; Ali J; Narang RS; Narang JK
    Drug Dev Ind Pharm; 2016; 42(2):209-20. PubMed ID: 26016780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Formulation And Evaluation Of Nanostructured Lipid Carriers (NLCs) Of 20(S)-Protopanaxadiol (PPD) By Box-Behnken Design.
    Kim MH; Kim KT; Sohn SY; Lee JY; Lee CH; Yang H; Lee BK; Lee KW; Kim DD
    Int J Nanomedicine; 2019; 14():8509-8520. PubMed ID: 31749618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formulation, Characterization, and Pharmacokinetic Studies of 6-Gingerol-Loaded Nanostructured Lipid Carriers.
    Wei Q; Yang Q; Wang Q; Sun C; Zhu Y; Niu Y; Yu J; Xu X
    AAPS PharmSciTech; 2018 Nov; 19(8):3661-3669. PubMed ID: 30324361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimization of Nanostructured Lipid Carriers of Lurasidone Hydrochloride Using Box-Behnken Design for Brain Targeting: In Vitro and In Vivo Studies.
    Jazuli I; Annu ; Nabi B; Moolakkadath T; Alam T; Baboota S; Ali J
    J Pharm Sci; 2019 Sep; 108(9):3082-3090. PubMed ID: 31077685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of Oral Lipid Based Nano-formulation of Dapagliflozin: Optimization, in vitro Characterization and ex vivo Intestinal Permeation Study.
    Zafar A
    J Oleo Sci; 2020; 69(11):1389-1401. PubMed ID: 33132278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paclitaxel-loaded Nanolipidic Carriers with Improved Oral Bioavailability and Anticancer Activity against Human Liver Carcinoma.
    Harshita ; Barkat MA; Rizwanullah M; Beg S; Pottoo FH; Siddiqui S; Ahmad FJ
    AAPS PharmSciTech; 2019 Jan; 20(2):87. PubMed ID: 30675689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, characterization and skin permeating potential of Fluocinolone acetonide loaded nanostructured lipid carriers for topical treatment of psoriasis.
    Pradhan M; Singh D; Murthy SN; Singh MR
    Steroids; 2015 Sep; 101():56-63. PubMed ID: 26049018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formulation of intranasal surface engineered nanostructured lipid carriers of rotigotine: Full factorial design optimization, in vitro characterization, and pharmacokinetic evaluation.
    Zafar A; Awad Alsaidan O; Alruwaili NK; Sarim Imam S; Yasir M; Saad Alharbi K; Singh L; Muqtader Ahmed M
    Int J Pharm; 2022 Nov; 627():122232. PubMed ID: 36155794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipid-based nano-formulation platform for eplerenone oral delivery as a potential treatment of chronic central serous chorioretinopathy:
    Abd-Elhakeem E; El-Nabarawi M; Shamma R
    Drug Deliv; 2021 Dec; 28(1):642-654. PubMed ID: 33787445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Finasteride-loaded nano-lipidic carriers for follicular drug delivery: preformulation screening and Box-Behnken experimental design for optimization of variables.
    Ramkar S; Suresh PK
    Heliyon; 2022 Aug; 8(8):e10175. PubMed ID: 36042733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy.
    Cirri M; Maestrini L; Maestrelli F; Mennini N; Mura P; Ghelardini C; Di Cesare Mannelli L
    Drug Deliv; 2018 Nov; 25(1):1910-1921. PubMed ID: 30451015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of Mucoadhesive Buccal Film for Rizatriptan: In Vitro and In Vivo Evaluation.
    Nair AB; Shah J; Jacob S; Al-Dhubiab BE; Patel V; Sreeharsha N; Shinu P
    Pharmaceutics; 2021 May; 13(5):. PubMed ID: 34063402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sorafenib-loaded nanostructured lipid carriers for topical ocular therapy of corneal neovascularization: development,
    Luo Q; Yang J; Xu H; Shi J; Liang Z; Zhang R; Lu P; Pu G; Zhao N; Zhang J
    Drug Deliv; 2022 Dec; 29(1):837-855. PubMed ID: 35277107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality by design approach to understand the process of optimization of iloperidone nanostructured lipid carriers for oral bioavailability enhancement.
    Mandpe L; Pokharkar V
    Pharm Dev Technol; 2015 May; 20(3):320-9. PubMed ID: 24328553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and machine-learning optimization of mucoadhesive nanostructured lipid carriers loaded with fluconazole for treatment of oral candidiasis.
    Elkomy MH; Elmowafy M; Shalaby K; Azmy AF; Ahmad N; Zafar A; Eid HM
    Drug Dev Ind Pharm; 2021 Feb; 47(2):246-258. PubMed ID: 33416006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic Design and Evaluation of Ticagrelor-Loaded Nanostructured Lipid Carriers for Enhancing Bioavailability and Antiplatelet Activity.
    Son GH; Na YG; Huh HW; Wang M; Kim MK; Han MG; Byeon JJ; Lee HK; Cho CW
    Pharmaceutics; 2019 May; 11(5):. PubMed ID: 31071977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Cremophor RH40, Hydroxypropyl Methylcellulose, and Mixing Speed on Physicochemical Properties of Films Containing Nanostructured Lipid Carriers Loaded with Furosemide Using the Box-Behnken Design.
    Kraisit P; Hirun N; Limpamanoch P; Sawaengsuk Y; Janchoochai N; Manasaksirikul O; Limmatvapirat S
    Polymers (Basel); 2024 Jun; 16(11):. PubMed ID: 38891551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Agranulocytosis-Protective Olanzapine-Loaded Nanostructured Lipid Carriers Engineered for CNS Delivery: Optimization and Hematological Toxicity Studies.
    Gadhave DG; Tagalpallewar AA; Kokare CR
    AAPS PharmSciTech; 2019 Jan; 20(1):22. PubMed ID: 30604305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral Bioavailability Enhancement of Raloxifene with Nanostructured Lipid Carriers.
    Murthy A; Ravi PR; Kathuria H; Malekar S
    Nanomaterials (Basel); 2020 May; 10(6):. PubMed ID: 32486508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Boosting the Brain Delivery of Atazanavir through Nanostructured Lipid Carrier-Based Approach for Mitigating NeuroAIDS.
    Khan SA; Rehman S; Nabi B; Iqubal A; Nehal N; Fahmy UA; Kotta S; Baboota S; Md S; Ali J
    Pharmaceutics; 2020 Nov; 12(11):. PubMed ID: 33172119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.